We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Epidemiology of dyslipidemia in chronic kidney disease.
- Authors
Iseki, Kunitoshi
- Abstract
Dyslipidemia is an established risk factor for atherosclerotic disease, such as stroke and ischemic heart disease, and is often detected in patients with chronic kidney disease (CKD). The role of dyslipidemia in CKD progression, however, is not well understood. CKD patients are heterogeneous and may include those who are malnourished or have hypoalbuminemia associated with proteinuria and a low estimated glomerular filtration rate (eGFR). Recent intervention trials showed no clear-cut benefits of statin treatment, particularly for CKD patients on dialysis. In CKD patients, multiple confounding variables such as proteinuria and the presence of cardiovascular disease may mask the effects of statins. Among them, proteinuria is a potent predictor of CKD progression (eGFR decline) and the development of end-stage renal disease. CKD patients are at high risk not only for end-stage renal disease, but also for cardiovascular disease, infection, malnutrition, and other comorbid conditions frequently associated with the elderly population. Evaluation and the target range of treatment of dyslipidemia should be individualized.
- Subjects
DYSLIPIDEMIA; EPIDEMIOLOGY; CHRONIC kidney failure; ATHEROSCLEROSIS risk factors; STATINS (Cardiovascular agents); GLOMERULAR filtration rate; CARDIOVASCULAR diseases
- Publication
Clinical & Experimental Nephrology, 2014, Vol 18, Issue 2, p185
- ISSN
1342-1751
- Publication type
Academic Journal
- DOI
10.1007/s10157-013-0891-8